No Time to Wait: Securing the Future from Drug-resistant Infections. Inter-Agency Coordination Group (IACG) on Antimicrobial Resistance. (2019)

immage

The 2016 Political Declaration of the High-level Meeting of the United Nations General Assembly on Antimicrobial Resistance represented a landmark in the world’s commitment to tackling antimicrobial resistance, calling for greater urgency and action in response to its many challenges. In the political declaration, Member States requested the Secretary-General, in consultation with the Food and Agriculture Organization of the United Nations (FAO), the World Organisation for Animal Health (OIE) and the World Health Organization (WHO) to convene an ad hoc interagency coordination group (IACG) co-chaired by the Executive Office of the Secretary-General and the Director-General of WHO to provide practical guidance for approaches needed to ensure sustained, effective global action to address antimicrobial resistance. It also requested the Secretary-General to submit a report for consideration by Member States by the seventy-third session of the General Assembly in 2019 on the implementation of the political declaration and on further developments and recommendations emanating from the IACG, including on options to improve coordination, considering the 2015 Global Action Plan on Antimicrobial Resistance.


This report presents the IACG’s response to the request from Member States in the 2016 political declaration and makes recommendations for urgent action for consideration by the Secretary-General, Member States and other stakeholders in the global response to antimicrobial resistance.

 

Download Report 


IACG Discussion Papers


1. Antimicrobial Resistance: Invest in Innovation and Research, and Boost R&D and Access

 

2. Antimicrobial Resistance: National Action Plans

 

3. Surveillance and Monitoring for Antimicrobial Use and Resistance

 

4. Future Global Governance for Antimicrobial Resistance

 

5. Optimize Use of Antimicrobials

 

6. Meeting the Challenge of Antimicrobial Resistance: From Communication to Collective Action

Regional HIV Forum 2018 for the Pacific Island Countries and Territories. UNAIDS, Fiji Network for People Living with HIV (FJN+) and UNDP Pacific. (2019)

immage

This document summarizes the proceedings of the Regional HIV Forum for the Pacific Island Countries and Territories 2018. The forum was the first event of its kind in the Western Pacific, bringing together people living with HIV and health care workers from across the region to meet, discuss and share their experiences working with and living with HIV. It provided a platform for open dialogue for both groups, enhancing HIV and antiretroviral therapy literacy, and self-empowerment, while aiming to catalyse coordination across HIV care, treatment and prevention programmes in the Pacific islands.

 

Keywords: HIV, ART, treatment, prevention

 

Download Publication

Updated List of DOH-Designated HIV Treatment Hubs and Primary HIV Care Facilities. Department of Health, Philippines. (2018)

immage

The DOH Administrative Order No. 2017-0019 or the Policies and Guidelines in the Conduct of Human Immunodeficiency Virus (HIV) Testing Services (HTS) in Health Facilities defines HIV Treatment hubs as a hospital with an organized HIV and AIDS Core Team (HACT) that facilitates in-patient and out-patient prevention, treatment, care and support services to PLHIV including but not limited to antiretroviral therapy, HIV testing services, clinical management, patient monitoring, and other care and support services.

 

 

Download Document

Transitioning to an Optimal Paediatric ARV Formulary: Implementation Considerations. WHO. (2018)

immage

Antiretroviral treatment (ART) optimization is a key pillar in the AIDS Free agenda to reach the goal of ensuring 95% of all infants and children have access to lifesaving treatment.

This policy brief outlines key considerations to facilitate effective transition to more clinically appropriate regimens as optimal ARV medicines and dosage forms become available.

 

Keywords: HIV, ARV, paediatric, treatment, children

 

Download Publication
 

HIV Self-testing: Quick and Simple. UNAIDS. (2018)

immage

The decision to take an HIV self-test is yours and yours alone. No one else should force you to take an HIV test, either an HIV self-test or any other type of HIV test.

 


Keywords: HIV, self-testing, privacy

 

 

Download Infographics

AIDS Free Framework to Accelerate Paediatric and Adolescent HIV Treatment. WHO. (2018)

immage

Every child and adolescent living with HIV should have access to antiretroviral therapy (ART). The AIDS Free component of the framework has the specific goal of ensuring 95% of all children and adolescents living with HIV have access to lifelong ART by the end of 2018. These efforts will need to be sustained until 2020, when it is estimated that treating 95% of all children and adolescents living with HIV will require providing ART to 1.4 million children (aged 0-14). and 1 million adolescents (aged 15-19).


Keywords: HIV, ART, children, adolescents, treatment

 

 

Download Publication

Sex Workers’ Experiences of Stock-outs of HIV/STI Commodities and Treatments. NSWP Global Network of Sex Work Projects and ITPC International Treatment Preparedness Coalition. (2018)

immage

Sex workers experienced stock-outs of antiretroviral drugs for HIV in more than half of the countries that responded to the consultation, in all types of health care settings. Sex workers experience forced treatment interruptions and involuntary medication changes due to stock-outs, and are forced to travel long distances to access commodities and treatments due to stock-outs in their local areas. This ultimately leads to a lack of trust in health services and systems.


Keywords: HIV, sex workers, drugs, health care, treatment

 


Download Community Guide and Briefing Paper

Progress Report on Access to Hepatitis C Treatment. WHO. (2018)

immage

This report updates the first edition, published in 2016, and reviews the progress countries have made in expanding access to life-saving DAAs. The report reviews the main challenges countries face and describes recent developments in relation to five key factors that determine access to DAA medicines: affordability, quality assurance, regulatory approval, government commitment and financing. It highlights key areas for action by ministries of health and other government decision-makers, pharmaceutical manufacturers and technical partners. 


Keywords: HCV, treatment, medicines, response

 

Download Publication

Ending an Epidemic: Prioritizing People who Inject Drugs in HCV Elimination Efforts. International AIDS Society (IAS). (2018)

immage

Nearly a quarter of the world’s new HCV infections occur among people who inject drugs (PWID): lack of access to sterile needles, syringes and other injection equipment renders them highly vulnerable to HCV. Legal and structural barriers also greatly increase HCV risk among PWID. Worldwide, more than 50% of the 15.6 million PWID are HCV antibody positive. Without urgent, strategic and measurable action that includes PWID, HCV will continue to inflict a staggering, and increasing, burden of preventable illness and death among families, communities and countries. 


Keywords: PWID, HCV, HIV,  treatment, harm reduction

 

Download Publication

An Informal Consultation on Validation of Elimination of Mother-to-Child Transmission of HIV, Hepatitis B and Syphilis. WHO Office of the Representative to Malaysia, Brunei Darussalam and Singapore. (2018)

immage

The consultation was convened in Malaysia (Putrajaya, 27 to 28 February 2018) by the Malaysian Ministry of Health and WHO to discuss potential approaches for validation of mother-to-child transmission of hepatitis B inviting national and international experts.

 

 


Keywords: HIV infections, child, maternal health, hepatitis B, syphilis

 

 

Download Publication

Pages

Data Dashboard
database
Highlighted publications
https://aidsdatahub.org/sites/default/files/highlight-reference/document/WHO_TB_Global_Report_2019.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/UNAIDS-Global-AIDS-Update_Asia-Pacific_2019.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/UNAIDS-changing-laws-that-discriminate_2019.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/PNG_HIV_National_Strategic_Information_2018-22.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/PNG_National_STI_and_HIV_Strategy.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/UNAIDS-young-peoples-participation-in-community-based-responses-to-hiv_2019.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/UNODC_factsheet_Ending_AIDS_by_2030_for_people_and_with_PUD_2018.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/UNAIDS_GAP_progress_report_2019.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/HRI-women-harm-reduction-2018.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/WHO_Elective_C-section_should_not_be_routinely_recommended_to_WLHIV_2018.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/ESCAP_Asia_and_the_Pacific_SDG_Progress_Report_2019.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/WHO_Guideline_on_digital_interventions_for_health_system_strengthening_2019.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/WHO_Progress_report_on_HIV_viral_hepatitis_and_STI_2019.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/UNAIDS_HIV_UHC_Guide_Civil_Society_2019.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/NSACP_Sri_Lanka_Annual_Report_2018.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/UNAIDS_HIV-related-travel-restrictions-explainer_2019.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/HIV-and-the-Law-supplement-2018.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/Myanmar_IBBS_and_Population_size_estimates_among_FSW_2015.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/Nepal_National_Community_Led_HIV_Testing_Guidelines_2018.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/Cambodia_IBBS_PWID_PWUD_2017.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/Cambodia_IBBS_FEW_2017.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/DataHub_TB-HIV_Fact_Sheet_2018.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/NSACP_Sri_Lanka_National_HIV_Communication_Strategy_2017.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/NACO_Status_of_National_AIDS_Response_2017.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/NACO_State_Epi_factsheets_V1_North-East_region_2017.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/NACO_State_Epi_factsheets_V2_West_South_region_2017.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/NACO_State_Epi_factsheets_V3_Northern_Central_Eastern_region_2017.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/WHO_Guidelines_for_Managing_Advanced_HIV_Disease_and_Rapid_Initiation_of_ART_2017.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/Cambodia_Estimations_and_projections_of_HIV_AIDS_at_Sub-national_level_2016-2020.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/WHO_HIV_drug_resistance_report_2017.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/Myanmar_National_Strategic_Plan_on_HIV_and_AIDS_2016-2020.pdf
Calendar of events
Oct
11
Nov
14
Nov
20